COMPUGEN LTD Proceeds from Sale and Maturity of Marketable Securities
COMPUGEN LTD (CGEN) reported Proceeds from Sale and Maturity of Marketable Securities of $50.31 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-03-02
| Period end | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|
| 2025-12-31 | $50.31M 20-F · filed 2026-03-02 | |
| 2025-06-30 | $21.64M 6-K · filed 2025-08-06 | |
| 2024-12-31 | $53.23M 20-F · filed 2026-03-02 | |
| 2024-06-30 | $15.82M 6-K · filed 2025-08-06 | |
| 2023-12-31 | $10.14M 20-F · filed 2026-03-02 | |
| 2022-12-31 | $0.00 20-F · filed 2025-03-04 | |
| 2021-12-31 | $0.00 20-F · filed 2024-03-05 | |
| 2016-12-31 | $369.00K 20-F · filed 2019-03-21 | |
| 2015-12-31 | $423.00K 20-F · filed 2018-03-27 | |
| 2014-12-31 | $2.31M 20-F · filed 2017-02-16 | |
| 2013-12-31 | $3.60M 20-F · filed 2016-03-07 |